COVID-19 (coronavirus)

Research Team

The Inflammatory Bowel Diseases Drug Discovery and Development unit’s team is comprised of research-scientists and clinicians with experience in the biopharmaceutical industry, as well as clinical research. Our team’s diverse background ensures we understand the biotech industry’s needs for drug development and creates better coordination and fosters interdisciplinary cooperation to advance the discovery and sharing of leading-edge knowledge to improve the lives of individuals living with inflammatory bowel disease.

Janine Bilsborough, PhD
Director, Inflammatory Bowel Disease Drug Discovery & Development, Associate Professor of Medicine
Stephan R. Targan, MD
Feintech Family Chair in Inflammatory Bowel Disease, Director, Inflammatory Bowel Disease Center, Director, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Dermot P. McGovern, MD, PhD
Joshua L. and Lisa Z. Greer Chair in Inflammatory Bowel Disease Genetics, Director, Translational Research in the Inflammatory Bowel and Immunobiology Research Institute, Professor, Medicine and Biomedical Sciences
Marie Fiorino
Biomedical Scientist, Lab Manager
Bradley Henkle
Associate Biomedical Scientist
Annabel Iwuchukwu
Biomedical Technician
Leah Kramer
Biomedical Technician
Alka Potdar, PhD
Senior Biomedical Scientist
Ignat Printsev, PhD
Biomedical Scientist
Lauren Ysais
Biomedical Technician

Have Questions or Need Help?

Contact us if you have questions, or wish to learn more about the IBD Drug Discovery and Development Unit at Cedars-Sinai.

8700 Beverly Blvd., Davis Building
Office: D4011 Lab: D4007
Los Angeles, CA 90048

Dermot McGovern, MD, PhD, FRCP
Janine Bilsborough, PhD